Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CORTEX PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 4.14 M 17.28 M 9.45 M 17.26 M 28.00 M
    Net Receivables 0.00 0.00 160,088.00 14,926.00 41,738.00
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 287,133.00 161,000.00 277,000.00
    Other Current Assets 154,884.00 246,960.00 364,819.00 240,535.00 30,717.00
    Current Assets Total 4.30 M 17.53 M 9.97 M 17.52 M 28.36 M
    Long Term Receivables 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 0.00 0.00 0.00 0.00 0.00
    Property, Plant & Equipment Net 809,458.00 850,647.00 427,884.00 438,841.00 387,818.00
    Property, Plant & Equipment Gross 3.62 M 3.50 M 2.95 M 2.86 M 2.74 M
    Accumulated Depreciation 2.81 M 2.65 M 2.52 M 2.42 M 2.35 M
    Other Assets 46,667.00 46,667.00 33,407.00 33,407.00 1.17 M
    Deferred Charges 1.14 M
    Tangible Other Assets 46,667.00 33,407.00 33,407.00 33,407.00
    Intangible Other Assets 0.00 0.00 0.00
    Total Assets 5.15 M 18.43 M 10.43 M 17.99 M 29.91 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 293,746.00 398,344.00 347,813.00 543,243.00 263,959.00
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 338,846.00 357,648.00 295,468.00 411,471.00 655,502.00
    Current Liabilities Total 1.76 M 1.73 M 2.06 M 2.81 M 2.29 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 22,576.00 247,000.00 727,000.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 0.00 25,119.00 58,050.00 49,988.00 3.96 M
    Total Liabilities 1.76 M 1.75 M 2.11 M 2.86 M 6.27 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 25,001.00 25,001.00 25,001.00 25,001.00 25,001.00
    Common Equity 3.37 M 16.65 M 8.30 M 15.11 M 23.62 M
    Common Stock 47,615.00 47,542.00 34,953.00 32,795.00 32,688.00
    Capital Surplus 112.68 M 111.34 M 90.05 M 81.00 M 77.96 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 0.00 0.00 0.00 -142,000.00 -195,250.00
    Unappropriated (Free) Reserves 0.00
    Retained Earnings -109.35 M -94.76 M -81.79 M -65.73 M -54.13 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -3,884.00 27,073.00 -3,205.00 -45,735.00 -48,116.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 5.15 M 18.43 M 10.43 M 17.99 M 29.91 M
    Common Shares Outstanding 47.62 M 47.54 M 34.95 M 32.79 M 32.69 M